Cisplatin + RT for Triple Negative Breast Cancer
Clinical trial NCT01674842 · COMPLETED
Trial details
- NCT number
- NCT01674842
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2018-08-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.